U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
162991162991The Efficacy and Safety of PerioChip Plus (Flurbiprofen/Chlorhexidine) Formulation in the Therapy of Adult PeriodontitisCompletedNo Results AvailablePeriodontitisDrug: PerioChip Plus (Flurbiprofen +Chlorhexidine ), Flurbiprofen Chip, PerioChip (Chlorhexidine ) and Placebo Chiphttps://ClinicalTrials.gov/show/NCT00425451
162992162992A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.TerminatedHas ResultsLupus NephritisDrug: Mycophenolate Mofetil|Drug: Corticosteroids|Drug: Azathioprine|Drug: Cyclophosphamidehttps://ClinicalTrials.gov/show/NCT00425438
162993162993Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal CancerActive, not recruitingNo Results AvailableEsophageal CancerBiological: cetuximab|Drug: fluorouracil|Drug: oxaliplatin|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00425425
162994162994Shiatsu Adjuvant Therapy For SchizophreniaCompletedNo Results AvailableSchizophreniaProcedure: Shiatsuhttps://ClinicalTrials.gov/show/NCT00425399
162995162995Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney CancerCompletedHas ResultsKidney CancerDrug: erlotinib hydrochloride|Drug: sunitinib malate|Procedure: biopsyhttps://ClinicalTrials.gov/show/NCT00425386
162996162996Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential HypertensionCompletedHas ResultsEssential HypertensionDrug: Valsartan + amlodipine 40/2.5 mg|Drug: Valsartan + amlodipine 40/5 mg|Drug: Valsartan + amlodipine 80/2.5 mg|Drug: Valsartan + amlodipine 80/5 mg|Drug: Valsartan 40 mg|Drug: Valsartan 80 mg|Drug: Amlodipine 2.5 mg|Drug: Amlodipine 5 mg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00425373
162997162997Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNo Results AvailablePancreatic CancerBiological: sargramostim|Biological: telomerase peptide vaccine GV1001|Drug: capecitabine|Drug: gemcitabine hydrochloridehttps://ClinicalTrials.gov/show/NCT00425360
162998162998Phase I, Multi-Center, Open-Label, Dose Escalation Study of HuLuc63 in Subjects With Advanced Multiple MyelomaCompletedNo Results AvailableMultiple MyelomaDrug: HuLuc63https://ClinicalTrials.gov/show/NCT00425347
162999162999Safety Study of Hemospan® in Prostatectomy PatientsCompletedNo Results AvailableBlood Loss, Surgical|Prostate Cancer|SurgeryDrug: Hemospan (MP4OX)|Drug: Ringer's lactatehttps://ClinicalTrials.gov/show/NCT00425334
163000163000Safety and Effectiveness Study of RWJ-445380 Cathepsin-S Inhibitor in Patients With Active Rheumatoid Arthritis Despite Methotrexate TherapyCompletedNo Results AvailableRheumatoid ArthritisDrug: RWJ-445380 100 mg|Drug: RWJ-445380 200 mg|Drug: RWJ-445380 300 mg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00425321
163001163001Efficacy and Safety of Everolimus in Combination With Cyclosporine Microemulsion Versus Everolimus in Combination With Enteric-coated Mycophenolate Sodium (EC-MPS), in Adult Renal Transplant Patients in Maintenance.CompletedHas ResultsRenal TransplantationDrug: Everolimus + Cyclosporine|Drug: Everolimus + Enteric-coated Mycophenolate Sodium (EC-MPS)|Drug: Steroidshttps://ClinicalTrials.gov/show/NCT00425308
163002163002Effectiveness of Human Simulation Training for Medical Crisis Management SkillsWithdrawnNo Results AvailableEducationBehavioral: Human Simulation Traininghttps://ClinicalTrials.gov/show/NCT00425295
163003163003A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.CompletedNo Results AvailableEpilepsy|Epilepsy, Focal|Seizure Disorder|Complex Partial Seizures|Epilepsy, Complex PartialDrug: RWJ-333369https://ClinicalTrials.gov/show/NCT00425282
163004163004Lifestyle Intervention for Pakistani Women in OsloCompletedHas ResultsMetabolic Syndrome|Type 2 DiabetesBehavioral: lifestyle intervention (diet and physical activity)https://ClinicalTrials.gov/show/NCT00425269
163005163005Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD)CompletedNo Results AvailableSexual Arousal DisorderDrug: Bremelanotidehttps://ClinicalTrials.gov/show/NCT00425256
163006163006Efficacy and Safety of Zolpidem-MR Administered Over a Long Term Period as Needed for Insomnia (ZOLONG)CompletedNo Results AvailableSleep Initiation and Maintenance DisordersDrug: zolpidem-MR (SL800750)https://ClinicalTrials.gov/show/NCT00425243
163007163007Open Label Study of Duloxetine for the Treatment of Phantom Limb PainTerminatedNo Results AvailableChronic Phantom Limb PainDrug: Duloxetinehttps://ClinicalTrials.gov/show/NCT00425230
163008163008Rituximab in Membranous NephropathyCompletedNo Results AvailableMembranous NephropathyDrug: Rituximabhttps://ClinicalTrials.gov/show/NCT00425217
163009163009Study for Patients Who Have Benefited and Tolerated Prior Panitumumab TreatmentCompletedNo Results AvailableColorectal Cancer|Non-Small Cell Lung Cancer|Prostate Cancer|Solid Tumors|Advanced Renal Cell CarcinomaDrug: Panitumumab (ABX-EGF)https://ClinicalTrials.gov/show/NCT00425204
163010163010Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer.CompletedNo Results AvailableNon-small Cell Lung CancerDrug: Docetaxel and Gemcitabine|Drug: Docetaxel and Gemcitabine|Drug: Gemcitabine cisplatin followed by docetaxelhttps://ClinicalTrials.gov/show/NCT00425191
163011163011FGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis UlcersCompletedNo Results AvailableChronic Wounds|Diabetes|Venous Stasis UlcersDrug: FGF-1https://ClinicalTrials.gov/show/NCT00425178
163012163012Study of Denufosol Inhalation Solution in Patients With Mild to Moderate Cystic Fibrosis Lung DiseaseTerminatedNo Results AvailableCystic FibrosisDrug: denufosol tetrasodium (INS37217) Inhalation Solutionhttps://ClinicalTrials.gov/show/NCT00425165
163013163013Fluorouracil and Leucovorin and/or Levamisole After Surgery In Treating Patients With Dukes' B Or Dukes' C Colon CancerCompletedNo Results AvailableColorectal CancerDrug: fluorouracil|Drug: leucovorin calcium|Drug: levamisole hydrochloridehttps://ClinicalTrials.gov/show/NCT00425152
163014163014Evaluation of a Video Game for Adolescents and Young Adults With CancerCompletedNo Results AvailableNeoplasmsBehavioral: Re-Missionhttps://ClinicalTrials.gov/show/NCT00425139
163015163015Effect of Procrit (Epoetin Alfa) on Preventing Delayed Graft Function After Deceased Donor Renal TransplantationCompletedNo Results AvailableDelayed Graft FunctionDrug: Epoetin Alfahttps://ClinicalTrials.gov/show/NCT00425126
163016163016Metronidazole for Pulmonary Tuberculosis (South Korea)CompletedHas ResultsTuberculosis|Multi-Drug Resistant TuberculosisDrug: Metronidazole|Procedure: Blood Draw|Procedure: CT Scan|Procedure: PET Scanhttps://ClinicalTrials.gov/show/NCT00425113
163017163017A Clinical Trial To Assess Fesoterodine On Treatment Satisfaction And Symptom Improvement In Overactive Bladder PatientsCompletedHas ResultsOveractive BladderDrug: fesoterodine fumaratehttps://ClinicalTrials.gov/show/NCT00425100
163018163018Pharmacodynamic-pharmacokinetic Trial, of Slow Release ASA, in the Platelet Functionalism.CompletedNo Results AvailableCardiovascular DiseaseDrug: slow release acetyl salicylic acid|Drug: ASA|Drug: SR-ASAhttps://ClinicalTrials.gov/show/NCT00425074
163019163019Study Evaluating the Effect of IMA-638 in Subjects With Persistent AsthmaCompletedHas ResultsAsthmaBiological: IMA-638|Biological: IMA-638|Other: placebohttps://ClinicalTrials.gov/show/NCT00425061
163020163020Does Gloved Medical Personnel Scratch Less Often?CompletedNo Results AvailableHygiene|Equipment Contamination|Health EducationProcedure: wearing gloveshttps://ClinicalTrials.gov/show/NCT00425048

* Görseller ve İçerik tekif hakkına sahip olabilir